Testosterone and Erectile Dysfunction: What Low T Actually Does (and Doesn't) Cause

Introduction

Most men dealing with erectile dysfunction are told one of two things. Either they're handed a PDE5 inhibitor (Viagra, Cialis) with no bloodwork discussion, or they fall down a rabbit hole suggesting that testosterone replacement therapy will "fix" their ED.

Neither story is complete.

Testosterone and erectile function are genuinely connected — low T can cause or contribute to ED, and bringing T levels into an optimal range does improve erections in a real subset of men. But the relationship isn't a simple dial. Most ED is vascular, not hormonal. And TRT is not a first-line ED treatment for men with normal testosterone levels.

Here's the honest breakdown: what low T actually does to erections, who benefits from TRT, and what works when testosterone isn't the problem.

The Physiology: How Testosterone Contributes to Erections

Erections involve three overlapping systems:

1. Vascular — nitric oxide (NO) triggers smooth muscle relaxation in the penile arteries, increasing blood flow. This is the primary mechanism and the target of PDE5 inhibitors.
2. Neurological — arousal signals travel from the brain and peripheral nerves. Damaged nerves (diabetic neuropathy, pelvic surgery) disrupt this pathway regardless of hormone status.
3. Hormonal — testosterone supports the vascular mechanism in two ways: it upregulates endothelial nitric oxide synthase (eNOS), the enzyme that produces NO; and it modulates sexual motivation through dopaminergic pathways in the brain.

When testosterone is low, both pathways suffer. eNOS activity decreases, reducing baseline NO production. Central dopamine signaling weakens, reducing the arousal signal that triggers the erectile response in the first place.

The result: a man with low T often experiences both reduced libido (the desire signal) and weaker erections (the vascular execution). These two symptoms travel together — which is why ED and low sex drive so frequently co-present in hypogonadal men.

Key distinction: Testosterone primarily acts as a permissive factor for erections, not a direct trigger. It sets the floor for vascular responsiveness and central arousal. Most of the acute erectile mechanism still runs through the NO/cGMP pathway.

When Low Testosterone Is the Primary Driver of ED

Low T causes ED most clearly in specific scenarios:

1. True hypogonadism with low T and low libido together If ED is accompanied by a significant decline in spontaneous erections (morning erections especially), a drop in sex drive, fatigue, and mood changes — and bloodwork confirms low testosterone — hormonal contribution is likely. TRT tends to work best in this pattern because the root deficit is real and measurable.

2. Secondary hypogonadism (pituitary/hypothalamic signal failure) When LH and FSH are inappropriately low alongside low T, the brain has stopped signaling the testes. This pattern often responds well to either TRT or enclomiphene (which restores the upstream signal without exogenous testosterone). Men in this group frequently report that their ED and libido recover significantly with treatment.

3. Age-related gradual decline Testosterone falls ~1–2% per year after age 40. In some men, crossing below a functional threshold — often somewhere in the 250–350 ng/dL range, but highly individual — unmasks an ED pattern that was previously absent. These men often describe a gradual worsening over several years, not an acute change.

When Low T Is NOT the Main Problem

This is the part that most TRT clinic marketing leaves out.

The research is clear: testosterone levels explain only about 5–10% of the variance in erectile function across the male population. Vascular disease, metabolic dysfunction, and neurological damage account for the large majority of ED cases — and none of those respond to testosterone.

The most common non-hormonal ED causes:

If a man has diabetes, cardiovascular risk factors, is on an SSRI, or has performance anxiety as the primary driver — optimizing testosterone will not fix the problem. TRT is not a substitute for addressing root-cause vascular and metabolic disease.

What the Research Shows: TRT's Effect on Erectile Function

The evidence that TRT improves ED is real — but the effect size matters.

In hypogonadal men: A 2016 Cochrane systematic review and meta-analysis found TRT produced a statistically significant improvement in erectile function scores in men with confirmed low T. Effect sizes were moderate, with the greatest benefit in men who had the lowest baseline T levels and in whom no vascular disease was identified.

The Testosterone Trials (NEJM 2016) showed meaningful improvement in sexual desire and activity in hypogonadal men — but erectile function improvement, while present, was smaller than the libido effect. This is consistent with the physiology: testosterone has a stronger effect on desire than on the vascular mechanics of erections.

Key finding: Men with the lowest baseline testosterone (below 230 ng/dL) showed the largest erectile function improvements. Men with T in the low-normal range (300–400 ng/dL) showed more modest gains.

In men with normal T: Multiple studies show that TRT does not reliably improve ED in men with normal testosterone levels. This is important: if bloodwork is normal and the ED has a vascular or psychological cause, testosterone will not help. This is a common disappointment for men who self-prescribe testosterone expecting it to function like Viagra.

The T Threshold for Erections vs. Libido

Testosterone has different "threshold" levels for different functions:

The practical implication: a man whose total T is 320 ng/dL might have acceptable libido but still experience ED that is partially hormonally mediated. He's above the libido threshold but possibly below his personal erectile threshold — and this is where free testosterone becomes important.

Free Testosterone Matters More Than Total T for Erectile Function

Total testosterone is the standard lab measurement, but free testosterone — the unbound fraction that tissues can actually use — determines functional hormone activity. Men with high SHBG (sex hormone-binding globulin) can have adequate total T but low free T, with real downstream effects on sexual function.

If your total T is "normal" (e.g., 450 ng/dL) but your SHBG is high (e.g., 60+ nmol/L), your free T could be functionally hypogonadal. This pattern is common in older men and men with metabolic dysfunction. It's frequently missed when clinics only check total T.

Run: Total T + free T (calculated or direct) + SHBG. Together, these three numbers tell a much more complete story than total T alone.

The Estradiol Factor: Crashed E2 Makes ED Worse

One of the most common and most avoidable causes of ED on TRT is excessive aromatase inhibitor (AI) use.

Testosterone aromatizes into estradiol. Many clinics reflexively prescribe anastrozole to "keep estrogen low." But estradiol (E2) plays a direct role in erectile function — it modulates nitric oxide signaling in penile endothelium and contributes to sexual motivation via the same central pathways as testosterone.

Men who over-suppress E2 (e.g., driving E2 below 15–20 pg/mL using anastrozole) frequently develop:

• Worsening ED despite adequate T levels
• Loss of morning erections
• Loss of libido
• Joint pain, low mood

This is a well-documented clinical phenomenon. If you're on TRT and your ED is worse than before you started, check your estradiol with a sensitive assay before assuming you need a higher testosterone dose. Crashed E2 mimics low T. The fix is reducing or eliminating the AI, not raising testosterone.

See: Anastrozole on TRT: When You Actually Need It for the full E2 management framework.

TRT + PDE5 Inhibitors: The Combination Protocol

For many men, TRT and a PDE5 inhibitor (sildenafil/Viagra, tadalafil/Cialis) work better together than either does alone. This is supported by data and increasingly common in clinical practice.

Why the combination works:

• Testosterone raises the baseline vascular floor (eNOS upregulation, NO production potential)
• PDE5 inhibitors prevent cGMP breakdown, sustaining vasodilation acutely
• Together, they address both the permissive hormonal environment and the acute vascular mechanism

Evidence: A 2016 systematic review in Sexual Medicine Reviews found that hypogonadal men who failed to respond to PDE5 inhibitors alone showed significantly improved responses when TRT was added. Conversely, men on TRT who didn't fully respond often added tadalafil low-dose daily with good results.

Practical note: If you're starting TRT for ED, don't expect immediate improvement. The vascular and neurological adaptations to optimized T take weeks to months. Most men see the clearest TRT-related erectile improvement at the 3–6 month mark, not in the first few weeks.

The sequence:

1. Get full bloodwork (total T, free T, SHBG, E2, CBC, metabolic panel)
2. Address confirmed hormonal deficit with TRT or enclomiphene
3. Optimize E2 (don't over-suppress with AI)
4. Give 3–4 months for neurological and vascular adaptation
5. Add low-dose daily tadalafil if partial response — this is often more effective than increasing T dose

Sleep Apnea: The Hidden Link

One more intersection worth understanding: sleep apnea suppresses testosterone by 20–40% through hypoxia-driven HPG disruption, elevated cortisol, and sleep fragmentation. It also causes ED directly — chronic intermittent hypoxia damages penile endothelial cells and reduces their NO capacity.

The result: men with untreated sleep apnea often have both low T AND ED that is vascular in origin — and it's tempting to treat the testosterone reading without treating the underlying apnea. TRT will partially compensate for the hormonal suppression, but it won't repair the vascular damage from repeated oxygen desaturations.

If you have ED and any of the following, screen for sleep apnea before or alongside TRT:

• Loud snoring
• Waking unrefreshed
• Daytime fatigue despite adequate sleep hours
• BMI > 30
• Neck circumference > 17 inches
• Witnessed apneas

Men with untreated apnea who start TRT also face elevated hematocrit risk from a dual erythropoietic stimulus. This requires more frequent CBC monitoring.

See: TRT and Sleep Apnea: The Bidirectional Risk for the full clinical framework.

Getting the Right Workup: Labs Before You Treat

If you have ED and are evaluating hormonal causes, here's the panel to run:

The key principle: don't treat ED with TRT based on symptoms alone. Confirm the hormonal diagnosis. If testosterone is clearly low and the ED fits the pattern, treat the deficit. If T is normal, the cause is almost certainly elsewhere.

Decision Framework: Testosterone, ED, and Your Next Step

Frequently Asked Questions

Q: Does low testosterone cause erectile dysfunction? A: Yes, it can — but it's responsible for a minority of ED cases. Low T primarily affects erectile function by reducing nitric oxide production in penile tissue and weakening the central arousal signal. Men with confirmed hypogonadism (low T plus symptoms) do see erectile improvement with TRT. However, most ED cases are primarily vascular, metabolic, or neurological in origin, and those won't respond to testosterone.

Q: What testosterone level causes erectile dysfunction? A: There's no universal cutoff, but erectile problems often become clinically significant when total testosterone falls below 300 ng/dL, and more pronounced below 230 ng/dL. Free testosterone is often more predictive than total T — men with high SHBG can have total T in range but free T too low to support adequate erectile function. The relevant threshold is also highly individual.

Q: Will TRT fix my ED? A: If your ED is driven by confirmed low testosterone, TRT often helps — particularly if you have low libido and poor morning erections alongside it. If your T is in the normal range, TRT is unlikely to fix ED that has a vascular or psychological cause. Many men with partial hormonal contribution benefit most from TRT plus a PDE5 inhibitor (tadalafil/Cialis) rather than either alone.

Q: How long does TRT take to improve erections? A: Most men see meaningful erectile improvement at 3–6 months. The early weeks of TRT may actually feel worse for some men as hormones recalibrate. Don't judge the erectile outcome at 4–6 weeks — the vascular and neurological adaptations take longer than the libido response. Morning erections typically return before full erectile reliability does.

Q: I'm on TRT and my ED got worse. Why? A: The most common cause is over-suppressed estradiol from anastrozole. Estradiol plays a direct role in erectile function — clinics that aggressively suppress E2 frequently create or worsen ED. Get a sensitive estradiol (LC-MS) assay. If it's below 20 pg/mL, reducing or eliminating your AI is almost certainly the fix. Also check whether your T dose is actually in range at trough.

Q: Can Viagra and TRT be used together? A: Yes, and this combination is often more effective than either alone. Testosterone supports the baseline vascular environment (eNOS upregulation), and PDE5 inhibitors (Viagra, Cialis) sustain the acute vasodilation during arousal. Hypogonadal men who don't fully respond to PDE5 inhibitors alone frequently achieve much better results when TRT is added to optimize T first.

Q: Does enclomiphene work for ED? A: Potentially yes for men with secondary hypogonadism. Enclomiphene restores pituitary LH/FSH signaling without suppressing the HPG axis, which raises endogenous testosterone. If the ED is driven by a true hormonal deficit, normalizing T levels through enclomiphene can help in the same way TRT does — while preserving fertility and testicular function. Not studied specifically for ED as a primary endpoint, but the mechanism is consistent.

Q: Is ED a sign of heart disease? A: It can be. Erectile dysfunction often precedes cardiovascular events by 3–5 years because penile arteries are smaller and develop atherosclerotic plaques earlier than coronary arteries. Men with new-onset unexplained ED who also have cardiovascular risk factors (hypertension, high cholesterol, diabetes, smoking) should discuss cardiac workup with their doctor — independent of testosterone status.

Image Concepts (On-Brand)

Image 1 — OG / Hero Card

• Format: 1200×630
• Layout: Split panel — left: testosterone T-molecule over a silhouette with low-light clinical setting; right: bold headline "Low T is real. But it's not most ED."
• Color: Dark background (#0F1117), white type, muted blue-green clinical accent
• Text overlay: Primary keyword confirmation — "Testosterone & Erectile Dysfunction: The Honest Breakdown"
• Alt text: "Diagram showing the difference between hormonal and vascular causes of erectile dysfunction"

Image 2 — Mechanism Inline Graphic

• Format: 800×500 infographic
• Concept: Three-system erectile pathway (Vascular → Nitric Oxide → cGMP / Neurological → Arousal Signal / Hormonal → T → eNOS → NO)
• Show where testosterone acts (eNOS upregulation node) vs. where PDE5 inhibitors act (cGMP breakdown prevention)
• Title: "Where Testosterone Actually Fits in the Erectile Pathway"
• Alt text: "Infographic showing vascular, neurological, and hormonal contributors to erectile function and where testosterone acts"

Image 3 — Decision Matrix Card

• Format: 800×600
• Concept: Stylized table card — "Your ED + Your T Level = Your Next Step" — 4 scenarios with color coding (green = TRT likely helps, yellow = combination approach, red = T not the issue)
• Clean typographic layout, dark background, high contrast
• Alt text: "Decision framework matching testosterone level and ED pattern to the best treatment approach"